Vistin Pharma ASA (OSL:VISTN)

Market Cap	878.02M
Revenue (ttm)	455.25M
Net Income (ttm)	78.06M
Shares Out	44.34M
EPS (ttm)	1.76
PE Ratio	11.25
Forward PE	n/a
Dividend	1.25 (6.25%)
Ex-Dividend Date	n/a

Volume	35,089
Average Volume	28,916
Open	20.20
Previous Close	20.00
Day's Range	19.70 - 20.20
52-Week Range	19.50 - 27.30
Beta	0.64
RSI	33.67
Earnings Date	Apr 24, 2026

About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1969
• Employees: 75
• Stock Exchange: Oslo Børs
• Ticker Symbol: VISTN

Financial Performance

In 2024, Vistin Pharma ASA's revenue was 429.50 million, a decrease of -2.01% compared to the previous year's 438.33 million. Earnings were 62.75 million, an increase of 37.62%.